Show simple item record

dc.contributor.authorZiver, Tevhide
dc.contributor.authorSaribas, Suat
dc.contributor.authorYuksel, Pelin
dc.contributor.authorCaliskan, Reyhan
dc.contributor.authorErgin, Sevgi
dc.contributor.authorAslan, Mustafa
dc.contributor.authorYALCINER, Altan
dc.contributor.authorKocazeybek, Bekir
dc.contributor.authorCelik, Deniz Gozde
dc.date.accessioned2021-03-05T09:25:28Z
dc.date.available2021-03-05T09:25:28Z
dc.date.issued2011
dc.identifier.citationYuksel P., Caliskan R., Ergin S., Aslan M., Celik D. G. , Saribas S., Ziver T., YALCINER A., Kocazeybek B., "New approaches to in vitro diagnosis of hepatitis C infection a reason for post transfusion hepatitis: Diagnostic value of determination of hepatitis C virus core antigen", TRANSFUSION AND APHERESIS SCIENCE, cilt.45, ss.247-250, 2011
dc.identifier.issn1473-0502
dc.identifier.otherav_9dcaf6d5-d9b6-4bcd-84a5-01ebc8db9413
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/105985
dc.identifier.urihttps://doi.org/10.1016/j.transci.2011.10.002
dc.description.abstractIn between the dates of February 2008-March 2009, by applying to Istanbul University CTF Microbiology and Clinical Microbiology Basic Sciences Branch and Duzen laboratories, 123 cases, where HCV RNA and anti-HCV positivity are identified with molecular (real-time PCR) and serologic (ELISA) methods as a positive control group, and 48 cases where FICV RNA and anti-HCV negativity are identified as a negative control group are established. The values of sensitivity, specificity, positive and negative approximation of recently developed HCV Core Ag (Abbott Diagnostics, Germany) kit are determined successively as 94.3%, 97.9%, 99.1%, 87%, 95.3% and 88%. Although the new HCV Ag assay is clearly not sensitive enough to replace HCV NAT it may serve as a valuable tool in the HCV diagnostic algorithm as it is able to pick up a great majority of anti-HCV and HCV RNA positive samples, thus allowing a timely and less expensive serological diagnosis of an active HCV infection. This may be an advantage for labs that do not have access to PCR easily. (C) 2011 Elsevier Ltd. All rights reserved.
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectHematoloji
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectHEMATOLOJİ
dc.titleNew approaches to in vitro diagnosis of hepatitis C infection a reason for post transfusion hepatitis: Diagnostic value of determination of hepatitis C virus core antigen
dc.typeMakale
dc.relation.journalTRANSFUSION AND APHERESIS SCIENCE
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume45
dc.identifier.issue3
dc.identifier.startpage247
dc.identifier.endpage250
dc.contributor.firstauthorID99797


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record